Pharmacor Olmesartan Amlodipine 20/5 olmesartan medoxomil 20 mg / amlodipine (as besilate) 5 mg tablets bottle pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

pharmacor olmesartan amlodipine 20/5 olmesartan medoxomil 20 mg / amlodipine (as besilate) 5 mg tablets bottle pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 20 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: silicified microcrystalline cellulose; stearic acid; pregelatinised maize starch; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Pharmacor Olmesartan Amlodipine 40/10 olmesartan medoxomil 40 mg / amlodipine (as besilate) 10 mg tablets bottle pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

pharmacor olmesartan amlodipine 40/10 olmesartan medoxomil 40 mg / amlodipine (as besilate) 10 mg tablets bottle pack

pharmacor pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: magnesium stearate; stearic acid; pregelatinised maize starch; croscarmellose sodium; silicified microcrystalline cellulose; titanium dioxide; iron oxide yellow; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

AKM Olmesartan Amlodipine 40/10 olmesartan medoxomil 40 mg / amlodipine (as besilate) 10 mg tablets blister pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

akm olmesartan amlodipine 40/10 olmesartan medoxomil 40 mg / amlodipine (as besilate) 10 mg tablets blister pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: stearic acid; pregelatinised maize starch; silicified microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

AKM Olmesartan Amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets bottle pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

akm olmesartan amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets bottle pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: magnesium stearate; stearic acid; silicified microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Pharmacor Olmesartan Amlodipine 20/5 olmesartan medoxomil 20 mg / amlodipine (as besilate) 5 mg tablets blister pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

pharmacor olmesartan amlodipine 20/5 olmesartan medoxomil 20 mg / amlodipine (as besilate) 5 mg tablets blister pack

pharmacor pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: stearic acid; pregelatinised maize starch; magnesium stearate; croscarmellose sodium; silicified microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

GENVOYA elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tablets Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

genvoya elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tablets

gilead sciences pty ltd - tenofovir alafenamide fumarate, quantity: 11.2 mg; emtricitabine, quantity: 200 mg; elvitegravir, quantity: 150 mg; cobicistat, quantity: 150 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; hyprolose; lactose monohydrate; magnesium stearate; sodium lauryl sulfate; microcrystalline cellulose; silicon dioxide; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - genvoya is indicated as a single tablet regimen for the treatment of hiv-1 infection in adults and paediatric patients weighing at least 25 kg who are either treatment?na?ve; or virologically suppressed (hiv-1 rna <50 copies/ml) on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see 5.1 pharmacodynamic properties, clinical trials). patients must not have a history of treatment failure or known mutations associated with resistance to the antiretroviral components of genvoya. genvoya is a fixed dose combination of one integrase inhibitor, one pharmacokinetic enhancer and two nucleos(t)ide hiv-1 reverse transcriptase inhibitors.

HALCION- triazolam tablet Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

halcion- triazolam tablet

pharmacia & upjohn company llc - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam 0.25 mg - halcion is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. halcion is contraindicated in: pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including halcion, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/pregnancyregistry/ risk summary neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal [see warnings and precautions (5.10) and ]. available data from published observational studies of pregnant women exposed to benzodiazepines do not report a clear association with benzodiazepines and major birth defects (see ) . the background risk of major birth defects and miscarriage for the indicated population is unknown. all pr

RIAMET 20 mg /120 mg artemether/lumefantrine 20 mg/120 mg dispersible tablet blister pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

riamet 20 mg /120 mg artemether/lumefantrine 20 mg/120 mg dispersible tablet blister pack

novartis pharmaceuticals australia pty ltd - artemether, quantity: 20 mg; lumefantrine, quantity: 120 mg - tablet, dispersible - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; crospovidone; saccharin sodium; hypromellose; magnesium stearate; polysorbate 80; colloidal anhydrous silica; flavour - riamet tablet is indicated for the treatment of acute, uncomplicated malaria due to plasmodium falciparum in adults, children and infants of 5kg and above. riamet dispersible tablet is indicated for the treatment of acute, uncomplicated malaria due to plasmodium falciparum in children and infants weighing between 5kg and less than 35kg.

STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

stribild tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle

gilead sciences pty ltd - tenofovir disoproxil fumarate, quantity: 300 mg; emtricitabine, quantity: 200 mg; elvitegravir, quantity: 150 mg; cobicistat, quantity: 150 mg - tablet, film coated - excipient ingredients: hyprolose; lactose monohydrate; microcrystalline cellulose; silicon dioxide; croscarmellose sodium; magnesium stearate; sodium lauryl sulfate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - stribild is indicated as a single tablet regimen for the treatment of hiv infection in treatment-na?ve adults. stribild is also indicated in certain virologically suppressed (hiv1 rna <50 copies/ml) adult patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see clinical trials). patients must not have a history of treatment failure or known mutations associated with resistance to the antiretroviral components of stribild (tenofovir df, emtricitabine or elvitegravir). stribild is a fixed dose combination of one integrase inhibitor, one pharmacokinetic enhancer and two nucleos(t)ide hiv-1 reverse transcriptase inhibitors.

RIAMET artemether/lumefantrine 20 mg/120 mg tablet blister pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

riamet artemether/lumefantrine 20 mg/120 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - lumefantrine, quantity: 120 mg; artemether, quantity: 20 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; polysorbate 80; croscarmellose sodium; hypromellose - riamet tablet is indicated for the treatment of acute, uncomplicated malaria due to plasmodium falciparum in adults, children and infants of 5kg and above. riamet is indicated for the treatment of acute, uncomplicated malaria due to plasmodium falciparum in patients aged at least 12 years and weighing at least 35kg.